Healthcare Industry News: NPWT
News Release - December 11, 2008
Introducing the Smith & Nephew Foam Dressing KitLaunch extends range of treatment options and empowers wound care professionals to use their clinical judgment to choose what is best for the patient, the wound and the care setting.
ST. PETERSBURG, Fla., Dec. 11 (Healthcare Sales & Marketing Network) -- The Advanced Wound Management Division of Smith & Nephew (LSE: SN ; NYSE: SNN ) is pleased to announce the introduction of a foam dressing kit for Negative Pressure Wound Therapy (NPWT). The new dressing kits will be launched in the market in the first quarter of 2009. The launch of the Smith & Nephew foam kit represents the first time wound care professionals will have the freedom to select either a gauze or foam wound interface from a single NPWT device manufacturer.
"Depending on the individual needs of the patient, the wound, and the care setting, health care professionals can now exercise their judgment to use either gauze or foam," says Joe Woody, President of Smith & Nephew's Advanced Wound Management Division. "We recognize that wound care should be in the hands of the clinicians and we want to supply them with the best options to select the right dressing for each patient."
The new Smith & Nephew foam kits will be supplied sterile and are available in four sizes. It is a single-use product designed to be clinically effective while intuitive to learn and easy to use.
"As the largest worldwide supplier of dressings, Smith & Nephew's core competency has historically focused around wound dressings," says Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "As a leader in advanced wound care interfaces, it only makes sense Smith & Nephew would introduce a foam dressing kit."
Negative Pressure Wound Therapy (NPWT)
NPWT is an effective and efficient method to healing advanced wounds. In comparison to traditional advanced wound therapies, negative pressure methods require less frequent dressing changes and often times a less painful treatment, combined with better healing of advanced wounds. The method can be used inside and outside of hospitals, and is not only a cost effective alternative to the hospital systems, but also allows patients to return to their normal lives as soon as possible.
The new kits are intended to be used in conjunction with Smith & Nephew NPWT systems to deliver negative pressure to wounds. Smith & Nephew NPWT systems are intended for patients who would benefit from a suction device and are appropriate on the following types of wounds:
- Pressure ulcers
- Diabetic/neuropathic ulcers
- Venous insufficiency ulcers
- Traumatic wounds
- Post-operative and dehisced surgical wounds
- Explored fistulas and
- Skin flaps and grafts
For more information regarding Smith & Nephew, please visit our Web site at www.smith-nephew.com or www.NPWT.com.
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Source: Smith & Nephew
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsSmith & Nephew to expand Real Intelligence digital ecosystem and CORI(TM) Surgical System with total hip arthroplasty
Smith & Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extremity Orthopaedics portfolio at AAOS
New data underscores material benefits of Smith & Nephew's OXINIUM(TM) DH Technology and OR3O(TM) Dual Mobility System for total hip arthroplasty versus Cobalt Chrome liners